SEC filing · 8-K

GT Biopharma, Inc.: Material agreement

GT Biopharma amended its private placement agreement to add a new purchaser and increase the offering size to $7,750,000.

Filed September 21, 2026

Positive for the company

What happened

On September 18, 2026, the company entered into the First Amendment to Securities Purchase Agreement with a new purchaser.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to GT Biopharma, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.